| |
| |
|
| Insider
Information: |
Snyderman Nancy Lynn Md |
| Relationship: |
Director |
| City: |
Dublin 4 |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
53,002 |
|
|
Indirect Shares
|
11,262 |
|
|
| Direct
Value |
$1,841,663 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
64,264 |
|
|
| Total
Value |
$1,841,663 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 4.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Axonics Modulation Technologies,... |
AXNX |
|
2023-06-26 |
19,944 |
2019-04-08 |
0 |
Premium* |
|
|
Lyra Therapeutics, Inc. |
LYRA |
Director |
2020-12-16 |
1,025 |
2020-12-16 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director |
2023-07-07 |
20,783 |
2021-05-20 |
0 |
Premium* |
|
|
Future Health Esg Corp. |
FHLT |
Director |
2021-10-24 |
11,250 |
2021-10-24 |
11,262 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
Director |
• • – |
2023-07-07 |
4 |
D |
$29.88 |
$42,728 |
D/D |
(1,430) |
20,783 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2023-07-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,957 |
22,213 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
|
– • – |
2023-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
19,944 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
|
– • – |
2022-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
16,944 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,585 |
16,951 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-06-14 |
4 |
D |
$27.19 |
$18,897 |
D/D |
(695) |
16,256 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-03-04 |
4 |
B |
$23.43 |
$10,005 |
D/D |
427 |
9,366 |
2.39 |
% |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-12-02 |
4 |
D |
$22.11 |
$29,605 |
D/D |
(1,339) |
8,939 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,578 |
10,278 |
0 |
- |
|
| FHLT |
Future Health Esg Corp. |
Director |
– • – |
2021-10-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,688) |
11,250 |
0 |
- |
|
| FHLT |
Future Health Esg Corp. |
Director |
– • – |
2021-10-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,689) |
11,262 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
|
– • – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,261 |
14,844 |
0 |
- |
|
| FHLT |
Future Health Esg Corp. |
Director |
– • – |
2021-09-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,951 |
|
- |
|
| FHLT |
Future Health Esg Corp. |
Director |
– • – |
2021-09-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,938 |
|
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-05-20 |
4 |
D |
$21.92 |
$30,776 |
D/D |
(1,404) |
4,700 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,104 |
6,104 |
0 |
- |
|
| LYRA |
Lyra Therapeutics, Inc. |
Director |
– • – |
2020-12-16 |
4 |
B |
$9.72 |
$9,963 |
D/D |
1,025 |
1,025 |
2.39 |
- |
|
| AXNX |
Axonics Modulation Techno... |
|
– • – |
2019-08-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,083 |
9,083 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
|
– • – |
2019-06-27 |
4 |
B |
$37.12 |
$74,240 |
D/D |
2,000 |
7,000 |
0.01 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Director |
– • – |
2019-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
